Literature DB >> 33535692

IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection.

Antonella De Donno1, Giambattista Lobreglio2, Alessandra Panico1, Tiziana Grassi1, Francesco Bagordo1, Maria Pia Bozzetti1, Serafina Massari1, Luisa Siculella1, Fabrizio Damiano1, Francesco Guerra2, Marilena Greco2, Michele Chicone2, Roberta Lazzari2, Pietro Alifano1.   

Abstract

The emergence of coronavirus disease 2019 (n class="Disease">COVID-19) is globally a major healthcare threat. There is little information regarding the mechanisms and roles of the humoral response in SARS-CoV-2 infection. The aim of this study was to analyze the antibody levels (IgM and IgG) by chemiluminescence immunoassay in 54 subjects positive to SARS-CoV-2 swab test in relation to their clinical status (whether asymptomatic, pauci-symptomatic or with mild, sever or critical symptoms), the time from the symptom onset, sex, age, and comorbidities. Overall, the presence of comorbidities and the age of subjects were associated with their clinical status. The IgG concentrations were significantly higher in patients who developed critical and severe symptoms and seemed to be independent from age, sex and comorbidities. IgG titers peaked around day 60, and then began gradually to drop, decreasing by approximately 50% on the 180th day, while the IgM titers progressively decreased as early as the tenth day, but they could be detected even at later time points. Despite the small number of individuals, some peculiar characteristics of the humoral response in COVID-19 emerged. We observed a high inter-individual variability, an ephemeral IgG half-life in several patients, and a persistence of IgM in others.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibodies; humoral immunity

Mesh:

Substances:

Year:  2021        PMID: 33535692     DOI: 10.3390/ijerph18031318

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  8 in total

1.  Rapid and Low-Cost Detection and Quantification of SARS-CoV-2 Antibody Titers of ICU Patients with Respiratory Deterioration Using a Handheld Thermo-Photonic Device.

Authors:  Damber Thapa; Nakisa Samadi; Andrew Baker; Claudia Dos Santos; Uriel Trahtemberg; Nima Tabatabaei
Journal:  Biomedicines       Date:  2022-06-15

Review 2.  Passive Immunity Should and Will Work for COVID-19 for Some Patients.

Authors:  Nevio Cimolai
Journal:  Clin Hematol Int       Date:  2021-04-16

3.  The relationship between IgG and IgM levels and severity of symptoms in COVID-19 patients confirmed by rapid antigen test.

Authors:  Jasim Saeed Salman Al-Ibraheemi; Abdul-Sattar Al-Saeedi
Journal:  J Med Life       Date:  2021 Nov-Dec

4.  Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients.

Authors:  Makoto Kurano; Hiroko Ohmiya; Yoshiro Kishi; Jun Okada; Yuki Nakano; Rin Yokoyama; Chungen Qian; Fuzhen Xia; Fan He; Liang Zheng; Yi Yu; Daisuke Jubishi; Koh Okamoto; Kyoji Moriya; Tatsuhiko Kodama; Yutaka Yatomi
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

5.  Antibody Response in Healthcare Workers before and after the Third Dose of Anti-SARS-CoV-2 Vaccine: A Pilot Study.

Authors:  Alessandra Panico; Giambattista Lobreglio; Francesco Bagordo; Antonella Zizza; Antonella De Donno; Chiara Rosato; Roberta Lazzari; Michele Chicone; Floriano Indino; Virginia Recchia; Pietro Alifano; Tiziana Grassi
Journal:  Vaccines (Basel)       Date:  2022-05-27

6.  Assessment of SARS-CoV-2 Infection among Healthcare Workers of a German COVID-19 Treatment Center.

Authors:  Lionel Larribère; Jelizaveta Gordejeva; Lisa Kuhnhenn; Maximilian Kurscheidt; Monika Pobiruchin; Dilyana Vladimirova; Maria Martin; Markus Roser; Wendelin Schramm; Uwe M Martens; Tatjana Eigenbrod
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

7.  Persistence of humoral response upon SARS-CoV-2 infection.

Authors:  Andrea Knies; Dennis Ladage; Ralf J Braun; Janine Kimpel; Miriam Schneider
Journal:  Rev Med Virol       Date:  2021-06-30       Impact factor: 11.043

8.  Association of the Serum Levels of the Nucleocapsid Antigen of SARS-CoV-2 With the Diagnosis, Disease Severity, and Antibody Titers in Patients With COVID-19: A Retrospective Cross-Sectional Study.

Authors:  Rin Yokoyama; Makoto Kurano; Yuki Nakano; Yoshifumi Morita; Hiroko Ohmiya; Yoshiro Kishi; Jun Okada; Chungen Qian; Fuzhen Xia; Fan He; Liang Zheng; Yi Yu; Miyuki Mizoguchi; Yoshimi Higurashi; Sohei Harada; Daisuke Jubishi; Koh Okamoto; Kyoji Moriya; Tatsuhiko Kodama; Yutaka Yatomi
Journal:  Front Microbiol       Date:  2021-12-09       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.